US 9856264
Isoquinolinesulfonyl derivative as RHO kinase inhibitor
granted A61KA61K31/4725A61K31/55
Quick answer
US patent 9856264 (Isoquinolinesulfonyl derivative as RHO kinase inhibitor) held by Medshine Discovery Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4725, A61K31/55, A61P, A61P27/06